{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/08/3270005/0/en/Plus-Therapeutics-Granted-U-S-FDA-Orphan-Drug-Designation-to-REYOBIQ-in-Pediatric-Malignant-Gliomas.html", "message": "News view counter 653122 successfully enlarged"}